NDC 50419-541

Kerendia

Finerenone

Kerendia is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals Inc.. The primary component is Finerenone.

Product ID50419-541_d7a7bc5e-c80a-4939-9e4f-e2fca6f55d25
NDC50419-541
Product TypeHuman Prescription Drug
Proprietary NameKerendia
Generic NameFinerenone
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-07-09
Marketing CategoryNDA /
Application NumberNDA215341
Labeler NameBayer Healthcare Pharmaceuticals Inc.
Substance NameFINERENONE
Active Ingredient Strength20 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50419-541-01

30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-541-01)
Marketing Start Date2021-07-09
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Kerendia" or generic name "Finerenone"

NDCBrand NameGeneric Name
50419-540Kerendiafinerenone
50419-541Kerendiafinerenone

Trademark Results [Kerendia]

Mark Image

Registration | Serial
Company
Trademark
Application Date
KERENDIA
KERENDIA
88432876 5931047 Live/Registered
Bayer Aktiengesellschaft
2019-05-16
KERENDIA
KERENDIA
87700817 5518140 Live/Registered
Bayer Aktiengesellschaft
2017-11-29

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.